Neurocrine Biosciences reported $393.5M in Operating Expenses for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Abbvie ABBV:US $ 11288M 2467M
Acadia Pharmaceuticals ACAD:US $ 168.21M 60.27M
Acorda Therapeutics ACOR:US $ 44.97M 5.73M
Agios Pharmaceuticals AGIO:US $ 100.52M 1.24M
Alnylam Pharmaceuticals ALNY:US $ 416.5M 56.51M
Amgen AMGN:US $ 4.42B 680M
Aptinyx Inc APTX:US $ 17.1M 2.27M
Biogen BIIB:US $ 2648.2M 727.1M
Biomarin Pharmaceutical BMRN:US $ 494.65M 112.61M
Cytokinetics CYTK:US $ 99.84M 18.14M
Dynavax Technologies DVAX:US $ 128.24M 45.01M
Enanta Pharmaceuticals ENTA:US $ 52.02M 544K
Exelixis EXEL:US $ 335.72M 62.98M
Gilead Sciences GILD:US $ 4231M 2162M
Halozyme Therapeutics HALO:US $ 118.3M 76.7M
Intercept Pharmaceuticals ICPT:US $ 85.12M 13.73M
Intra Cellular Therapies ITCI:US $ 143.5M 35.84M
Nektar Therapeutics NKTR:US $ 174.42M 33.04M
Neurocrine Biosciences NBIX:US $ 393.5M 86M
Pfizer PFE:US $ 15640M 148M
Prothena PRTA:US 44.52M 5.42M
Regeneron Pharmaceuticals REGN:US $ 1747.3M 40.7M
Repligen RGEN:US $ 144.46M 1.93M
Rigel Pharmaceuticals RIGL:US $ 42.78M 212K
Sarepta Therapeutics SRPT:US $ 444.62M 146.91M
Teva Pharmaceutical TEVA:IT 4.74B 361M
Ultragenyx Pharmaceutical RARE:US $ 230.94M 14.37M
Vertex Pharmaceuticals VRTX:US $ 1089.9M 33.3M
Xoma XOMA:US $ 5.75M 578K
YTE INCY:US $ 656.97M 40.27M